Post-effective amendment to a registration statement that is not immediately effective upon filing

Cover Page

v3.23.1
Cover Page
 12 Months Ended
Dec. 31, 2022
Document Information [Line Items]  
Document Type POS AM
Amendment Flag true
Entity Registrant Name INHIBIKASE THERAPEUTICS, INC.
Entity Central Index Key 0001750149
Entity Filer Category Non-accelerated Filer
Entity Emerging Growth Company true
Entity Small Business true
Entity Ex Transition Period false
Entity Tax Identification Number 26-3407249
Entity Address, Address Line One 3350 Riverwood Parkway SE
Entity Address, Address Line Two Suite 1900
Entity Address, City or Town Atlanta
Entity Address, State or Province GA
Entity Address, Postal Zip Code 30339
City Area Code 678
Local Phone Number 392-3419
Entity Incorporation, State or Country Code DE
Entity Primary SIC Number 2836
Amendment Description On February 1, 2023, we filed a registration statement on Form S-1 (No. 333-269521) (the “Registration Statement”), which registered for resale from time to time (i) up to 11,627,908 shares of common stock, par value $0.001 per share (the “Common Stock”), which the selling stockholders (the “Selling Stockholders”) may acquire upon the exercise of outstanding warrants (the “Common Warrants”), (ii) up to 4,883,721 shares of Common Stock, which the Selling Stockholders may acquire upon the exercise of outstanding pre-funded warrants (the “Pre-Funded Warrants”), and (iii) up to 406,977 shares of Common Stock, which the Selling Stockholders may acquire upon the exercise of outstanding placement agent warrants (the “Placement Agent Warrants”, and together with the Common Warrants, and Pre-Funded Warrants, the “Warrants”). We issued the Common Warrants and Pre-Funded Warrants to the Selling Stockholders in private placements concurrent with a registered direct offering of 2,800,789 shares of Common Stock and Pre-Funded Warrants to purchase 3,943,398 shares of Common Stock. We issued the Placement Agent Warrants to Selling Stockholders as designees of H.C. Wainwright & Co., as placement agent fees for serving as the exclusive placement agent in the registered direct offering and concurrent private placements. The closing of the issuance and sale of these securities was consummated on January 27, 2023. The Registration Statement was declared effective by the Securities and Exchange Commission on February 7, 2023. This post-effective amendment is being filed to include information from our Annual Report on Form10-K for the year ended December 31, 2022 that was filed on March 31, 2023. No additional securities are being registered under this post-effective amendment and all applicable registration and filing fees were paid at the time of the original filing of the Registration Statement.
Business Contact [Member]  
Document Information [Line Items]  
Entity Address, Address Line One 3350 Riverwood Parkway SE
Entity Address, Address Line Two Suite 1900
Entity Address, City or Town Atlanta
Entity Address, State or Province GA
Entity Address, Postal Zip Code 30339
City Area Code 678
Local Phone Number 392-3419
Contact Personnel Name Milton H. Werner